CELZ - Creative Medical Technology Holdings, Inc.
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 8.76M |
| Enterprise Value | 9.13M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 81.44 |
| Price/Book (mrq) | 0.59 |
| Enterprise Value/Revenue | 123.99 |
| Enterprise Value/EBITDA | -0.92 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 5.18 |
| 52-Week Change 3 | -41.05% |
| S&P500 52-Week Change 3 | 2.54% |
| 52 Week High 3 | 1.4200 |
| 52 Week Low 3 | 0.3300 |
| 50-Day Moving Average 3 | 0.6000 |
| 200-Day Moving Average 3 | 0.5456 |
Share Statistics
| Avg Vol (3 month) 3 | 1.82M |
| Avg Vol (10 day) 3 | 723.24k |
| Shares Outstanding 5 | 14.08M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 12.83M |
| % Held by Insiders 1 | 2.54% |
| % Held by Institutions 1 | 7.77% |
| Shares Short (May 14, 2023) 4 | 327.3k |
| Short Ratio (May 14, 2023) 4 | 0.9 |
| Short % of Float (May 14, 2023) 4 | 2.39% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 2.33% |
| Shares Short (prior month Apr 13, 2023) 4 | 1.33M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:500 |
| Last Split Date 3 | Nov 09, 2021 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -13,862.19% |
Management Effectiveness
| Return on Assets (ttm) | -51.09% |
| Return on Equity (ttm) | -83.07% |
Income Statement
| Revenue (ttm) | 73.6k |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -10.11M |
| Net Income Avi to Common (ttm) | -10.04M |
| Diluted EPS (ttm) | -0.7700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.56M |
| Total Cash Per Share (mrq) | 1.03 |
| Total Debt (mrq) | 14.19k |
| Total Debt/Equity (mrq) | 0.10 |
| Current Ratio (mrq) | 36.35 |
| Book Value Per Share (mrq) | 1.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10.06M |
| Levered Free Cash Flow (ttm) | -6.4M |
© 2023 Yahoo. All rights reserved.